A cost-effectiveness analysis alongside trial of a digital health-supported and community pharmacy-based prediabetes management programme (PRIME Programme) in Malaysia.

Diabetes Obes Metab · 2025 · PMC12046470 · PMID 40123297

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

CONCLUSION In conclusion, although the improvement in quality of life did not reach statistical significance, the PRIME intervention showed significant changes in BMI reduction, which is an important risk factor for diabetes.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.